The two pharmaceutical companies Hamlet Pharma AB and SelectImmune Pharma AB, listed on the Spotlight Stock Market, intend to merge and create a powerful pharmaceutical…
Read More
Financial news
Opening remarks During the second quarter of the fiscal year, Hamlet Pharma has made significant progress in its clinical trial program for Alpha1H, a drug…
Opening remarks The HAMLET family of drug candidates has remarkable effects and continues to show great promise for the prevention and treatment of cancer. Alpha1H…